Details of the Drug
General Information of Drug (ID: DMZ9L6Q)
Drug Name |
3-((1H-imidazol-1-yl)methyl)aniline
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3-(1H-imidazol-1-ylmethyl)aniline; 120107-85-9; 3-((1H-imidazol-1-yl)methyl)aniline; 3-(1-Imidazolylmethyl)aniline; 3-(imidazol-1-ylmethyl)aniline; Benzenamine, 3-(1H-imidazol-1-ylmethyl)-; 3-Imidazol-1-ylmethyl-phenylamine; Benzenamine,3-(1H-imidazol-1-ylmethyl)-; CHEMBL597369; 3-(imidazolylmethyl)phenylamine; 3-[(1H-Imidazol-1-yl)methyl]aniline; ACMC-20e0av; AC1Q51NE; 1-(3-aminobenzyl)imidazole; SCHEMBL860653; 3-(Imidazo-1-ylmethyl)aniline; AC1O5C89; CTK4B1687; DTXSID20424305; MolPort-000-143-257
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 173.21 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||